Perrigo | PRGO - Operating Expenses


Perrigo reported $949.9M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
AbbVie USD -2.64B 12.35B Sep/2025
Abbott USD 9.21B 17M Dec/2025
Bayer EUR 10.2B 523M Sep/2025
Bristol-Myers Squibb USD 18.55B 10.06B Sep/2025
Corcept Therapeutics USD 197.42M 29.66M Sep/2025
Dr.Reddys Laboratories INR 73.6B 1.79B Dec/2025
Eli Lilly USD 9.21B 677.8M Sep/2025
J&J USD 18.97B 2.38B Dec/2025
Merck USD 10.72B 1.28B Sep/2025
Nestle CHF 37.09B 1.39B Jun/2025
Pacira USD 166.36M 4.5M Sep/2025
Perrigo USD 949.9M 50.8M Sep/2025
Pfizer USD 92.8B 82.47B Sep/2025
Prestige Brands USD 194.44M 16.67M Sep/2025
Reckitt Benckiser GBP 6.26B 3.51B Dec/2024
Sanofi EUR 10.51B 1.21B Dec/2025
Supernus Pharmaceuticals USD 252.29M 98.98M Sep/2025
Teva Pharmaceutical Industries USD 4.22B 812M Dec/2025
Xeris Pharmaceuticals USD 67.65M 590K Sep/2025
Zoetis USD 5.4B 3.94B Sep/2025